相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study.
Jennifer Leddon et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC).
Ravindra Uppaluri et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Robert L. Ferris et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Renata Ferrarotto et al.
CLINICAL CANCER RESEARCH (2020)
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri et al.
CLINICAL CANCER RESEARCH (2020)
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer et al.
CANCER CELL (2020)
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
Jonathan D. Schoenfeld et al.
JAMA ONCOLOGY (2020)
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma.
Joshua Dean Horton et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative
Matthew C. Ward et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma.
Trisha Michel Wise-Draper et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
Glenn J. Hanna et al.
ORAL ONCOLOGY (2017)
Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival
Marc Hamoir et al.
ORAL ONCOLOGY (2017)
Validation of OncoPanel A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer
Elizabeth P. Garcia et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria
Anna Merlotti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience
Vlad C. Sandulache et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences
Danielle N. Margalit et al.
ORAL ONCOLOGY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
f Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M. Sholl et al.
JCI INSIGHT (2016)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Decision making in the management of recurrent head and neck cancer
Allen S. Ho et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
Sonia Norris et al.
VIRAL IMMUNOLOGY (2012)
Outcomes of Salvage Surgery With Free Flap Reconstruction for Recurrent Oral and Oropharyngeal Cancer
John P. Kostrzewa et al.
LARYNGOSCOPE (2010)
The Role of Salvage Surgery in Patients With Recurrent Squamous Cell Carcinoma of the Oropharynx
Mark E. Zafereo et al.
CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Final report of rtog 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
Sharon A. Spencer et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma
Francois Janot et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Individual patients' data meta-analyses in head and neck cancer
Jean Bourhis et al.
CURRENT OPINION IN ONCOLOGY (2007)
Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma
N Kasperts et al.
CANCER (2006)
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
B Brockstein et al.
ANNALS OF ONCOLOGY (2004)
PoStoperative complications after en bloc salvage surgery for head and neck cancer
IMG Agra et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means?
WJ Goodwin
LARYNGOSCOPE (2000)
分享论文
